Multi-Omics Map of Chinese Cervical Cancer Patients Reveals New Drug Targets
An integrated multi-omics study of 112 Chinese cervical cancer patients reveals key driver mutations, immune phenotypes, and promising therapeutic targets.
An integrated multi-omics study of 112 Chinese cervical cancer patients reveals key driver mutations, immune phenotypes, and promising therapeutic targets.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.